Likes Subject
AMGEN INC is having a great day! MiamiGent 11/08/22 12:04 PM
WAS SUPPOSED TO BE BIG IN pm ernie44 02/04/22 9:30 AM
I was reading on another board where someone all the way up green 01/04/22 11:44 PM
investorshub.advfn.com/uimage/uploads/2021/8/13/ocrlnamgn_8_11_9y_cr_trw_ nowwhat2 08/13/21 9:12 AM
wee BottomBounce 08/04/21 9:16 AM
More great news. Should be back to 250 Actualfactual 06/04/21 10:02 AM
FDA approves Lumakras—(f/k/a AMG-510)—for_second-line KRAS-mutated NSCLC: DewDiligence 05/28/21 1:48 PM
LOL. That mod spot is available Jimmy Swaggert 04/29/21 1:38 PM
The charts are annoying on this page. PennyStocksGuru 02/16/21 2:47 AM
$AMGN vs $GILD BottomBounce 10/24/20 8:39 AM
Next week at ACC: north40000 03/26/20 12:47 PM
Typical BIO Milestone and Shorts try a wreck Pyramid2 11/18/19 6:18 PM
News: $AMGN Amgen Announces New FOURIER Analysis Showing whytestocks 11/16/19 9:30 AM
Lost a suit, AH news today: D.Court judge north40000 08/28/19 4:43 PM
Wow win a lawsuit and that’s it? Should KingTigerII 08/15/19 4:49 PM
Please visit our IHUB message board for updates! ;) TFMG 06/03/19 11:00 PM
Amgen Sun. Highlighted New Data From Phase 1 crudeoil24 06/03/19 10:52 AM
$AMGN A big week ahead for Amgen, now TFMG 06/02/19 11:12 AM
Here's A Leading Biotech Stock That Is Getting Attractive ITMS 05/30/19 12:23 PM
Amarin, Amgen Platinum Sponsors; EAS Congress, May 26-29 north40000 05/27/19 11:17 AM
Good results might not be good enough. Cautious. TFMG 04/30/19 7:33 PM
News: $AMGN Amgen Presents New Data At WCO-IOF-ESCEO whytestocks 04/07/19 8:00 AM
AMGN 4Q18 CC slides: DewDiligence 01/29/19 4:18 PM
News: $AMGN deCODE Publishes the First Full Resolution whytestocks 01/24/19 2:51 PM
News: $AMGN European Commission Approves BLINCYTO® (blinatumomab) In whytestocks 01/22/19 11:11 AM
We visited the AMGN booth at AHA this north40000 11/14/18 3:32 PM
AMGN 3Q18 items… DewDiligence 10/30/18 6:14 PM
$24 is erroneous, should be $9 co-pay for north40000 10/22/18 1:08 AM
AMGN, NVS launch Humira biosimilars in Europe, pursuant DewDiligence 10/16/18 11:24 AM
AMRN, AMGN mentioned here: north40000 09/24/18 1:41 PM
AMGN 2Q18 CC slides: DewDiligence 07/26/18 4:58 PM
$AMGN and 3 Drug and Biotech Stocks Awaiting BottomBounce 07/13/18 10:10 AM
AMGN completes $10B buyback via tender offer for DewDiligence 03/06/18 11:47 AM
AMGN 4Q17 CC slides: DewDiligence 02/01/18 5:00 PM
Head And Shoulder Pattern Formation On Amgen, Inc. ITMS 12/27/17 12:40 PM
You are doing an excellent job...... following u winner06 11/20/17 10:02 PM
This Biotech Stock Struggles To Hold Key Level ITMS 11/20/17 12:53 PM
AMGN 3Q17 CC slides: DewDiligence 10/25/17 4:24 PM
https://seekingalpha.com/article/4107923-amgen-allergan-avastin-biosimilar-appro Inoviorulez 09/19/17 6:49 PM
https://seekingalpha.com/article/4092782-amgen-looks-enhance-cholesterol-drug Inoviorulez 07/31/17 5:45 PM
AMGN 2Q17 CC slides: DewDiligence 07/25/17 4:39 PM
https://seekingalpha.com/article/4089618-amgen-novartis-first-mover-advantage-mu Inoviorulez 07/23/17 2:28 AM
https://seekingalpha.com/article/4088415-amgen-receives-crl-osteoporosis-drug-ne Inoviorulez 07/18/17 11:43 AM
https://seekingalpha.com/article/4087466-amgen-receives-fda-approval-blincyto Inoviorulez 07/13/17 9:18 AM
The ins and outs of the Amgen v HONEYDEG 06/13/17 12:25 PM
The ins and outs of the Amgen v HONEYDEG 06/13/17 12:25 PM
http://news.sky.com/story/ovarian-cancer-drug-hailed-as-biggest-breakthrough-in- sci101 06/03/17 1:48 PM
Confidential Treatment Order (ct Order) TREND1 05/30/17 3:55 PM
DEW here is exact post TREND1 05/30/17 3:37 PM
SEE MNKD BOARD TREND1 05/30/17 3:35 PM
Likes Subject

MiamiGent
11/08/22 12:04 PM
ernie44
02/04/22 9:30 AM
all the way up green
01/04/22 11:44 PM
BottomBounce
08/04/21 9:16 AM
wee
Actualfactual
06/04/21 10:02 AM
Jimmy Swaggert
04/29/21 1:38 PM
PennyStocksGuru
02/16/21 2:47 AM
BottomBounce
10/24/20 8:39 AM
north40000
03/26/20 12:47 PM
north40000
08/28/19 4:43 PM
KingTigerII
08/15/19 4:49 PM
crudeoil24
06/03/19 10:52 AM
TFMG
06/02/19 11:12 AM
DewDiligence
01/29/19 4:18 PM
north40000
11/14/18 3:32 PM
DewDiligence
10/30/18 6:14 PM
north40000
10/22/18 1:08 AM
north40000
09/24/18 1:41 PM
DewDiligence
07/26/18 4:58 PM
BottomBounce
07/13/18 10:10 AM
DewDiligence
03/06/18 11:47 AM
DewDiligence
02/01/18 5:00 PM
DewDiligence
10/25/17 4:24 PM
DewDiligence
07/25/17 4:39 PM
HONEYDEG
06/13/17 12:25 PM
HONEYDEG
06/13/17 12:25 PM
TREND1
05/30/17 3:37 PM
TREND1
05/30/17 3:35 PM

Amgen (AMGN)

Followers
16
Posters
95
Posts (Today)
0
Posts (Total)
439
Created
09/06/05
Type
Free
Moderators
This board is for fundamental and technical discussion about Amgen, AMGN. Amgen Inc. (Amgen) is a global biotechnology company. It discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. It markets human therapeutic products in the areas of supportive cancer care, nephrology, inflammation and oncology. In September 2006, Vectibix (panitumumab), Amgen's first oncology therapeutic, received the United States Food and Drug Administration approval and became commercially available in October 2006. The Company's principal products include Aranesp (darbepoetin alfa), Neulasta (pegfilgrastim), NEUPOGEN (Filgrastim), EPOGEN (Epoetin alfa) and Enbrel (etanercept). On April 1, 2006, Amgen acquired Vectibix as part of its acquisition of Abgenix, Inc. On October 24, 2006, it acquired Avidia, Inc., which discovered and developed a class of human therapeutic known as Avimer proteins. In July 2007, it acquired Alantos and Ilypsa. Share Price: $40.11 3/20/2008 52 Week High: $69.11 52 Week Low: $39.16 EPS: $2.82 P/E Ratio: 14.22 Outstanding Shares: 1.09 Billion AMGEN INC 1 Amgen Center Dr Thousand Oaks, CA 91320-1799 USA Phone: 805-447-1000 Fax: 805-447-1010 http://www.amgen.com Daily One-Year Charts Weekly Five-Year Charts
Most Liked Posts
(Last 30 Days)
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Most Liked Posts
(Last 30 Days)
New Post